Intermediates and probes for synthesizing novel cyclometallated iridium complex fluorescent probes, and preparation methods and applications thereof

Through the electrostatic binding and acid migration characteristics of the fluorescent probe of the new ring metal iridium (III) complex, the cytotoxicity and photostability of the fluorescent probe in the prior art were solved, and the dynamic changes of the mitochondrial membrane potential were achieved. The long-term reversible monitoring has excellent optical properties and biocompatibility, and is suitable for biomedical research.

CN116284149BActive Publication Date: 2024-11-26ANQING NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310249393.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-15
Publication Date
2024-11-26
Estimated Expiration
2043-03-15

AI Technical Summary

Technical Problem

The existing fluorescent probes for mitochondrial membrane potential monitoring have problems such as high cytotoxicity, instability, poor water solubility, small Stokes displacement and dissociation into the cytoplasm after the membrane potential decreases, resulting in fluorescence quenching, making it difficult to achieve resuming membrane potential. The application of targeting mitochondria, and organic small molecule fluorescent probes are prone to photobleaching during long-term detection, limiting the detection of mitochondrial membrane potential fluctuations.

Method used

Using a new ring metal iridium (III) complex fluorescent probe, it combines with the negative membrane potential of mitochondria through electrostatic action, emits near-infrared fluorescence, and migrates to the lysosome through protonation of pyridine groups under acidic conditions, achieving reversibility Migrate to avoid diffusion in the cytoplasm, and combine phenylpyridine, iridium trichloride and 2-pyridine tripyridine as raw materials to synthesize the probe efficiently.

Benefits of technology

It realizes long-term reversible monitoring of dynamic changes in mitochondrial membrane potential. The probe has excellent optical properties and biocompatibility, can migrate reversibly multiple times, and quantitative monitoring is achieved through confocal imaging technology, overcoming the shortcomings of the existing technology. It has potential biomedical application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116284149B_ABST
    Figure CN116284149B_ABST
Patent Text Reader

Abstract

The invention discloses an intermediate, a probe, a preparation method and an application for synthesizing a novel cyclometallated iridium complex fluorescent probe, and belongs to the technical field of mitochondrial membrane potential dynamic monitoring. The structural formula of the intermediate is shown in Formula I; the structural formula of the fluorescent probe is shown in Formula II below; when preparing the probe, phenylpyridine and iridium trichloride are used as raw materials to synthesize the intermediate, and then the intermediate is mixed with 2-pyridine terpyridine to prepare the novel cyclometallated iridium complex fluorescent probe M-Ir-L; the probe has good photophysical properties, can be used as a mitochondrial-lysosomal reversible migration fluorescent probe, and can achieve the effect of tracking and detecting the dynamic changes of mitochondrial membrane potential in cells in different physiological environments through long-term reversible migration#imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of dynamic monitoring of mitochondrial membrane potential, and more specifically to a novel cyclometallic complex fluorescent probe and a preparation method and application thereof. Background Art

[0002] As a dynamic organelle, mitochondria not only generate energy for the growth, development and metabolism of the body, but also play an important role in regulating the homeostasis and apoptosis of cells in adverse microenvironments. Due to the existence of the oxidative respiratory chain on the inner membrane of mitochondria, protons are continuously pumped out during oxidative respiration, thus maintaining the existence of mitochondrial membrane potential (-180mV). This parameter is also an important indicator of the metabolic function and activity of mitochondria and even cells. In addition, the membrane potential is closely related to some mitochondrial-related metabolic diseases such as neurodegenerative diseases Parkinson's disease, Alzheimer's disease, and atherosclerosis to varying degrees. Therefore, the real-time and highly sensitive monitoring of mitochondrial membrane potential has important application value in the fields of biomedical research and cell biology mechanism research.

[0003] Currently, the commercial dyes developed based on mitochondrial membrane potential include Rhodamine 123, Mito-tracker GreenFM, Mito-tracker Red and Mito-tracker Deep Red FM, all of which have good mitochondrial membrane potential targeting in living cells and emit obvious fluorescence signals. However, they are highly cytotoxic, photoinstable, poorly water-soluble, have small Stokes shifts, and dissociate into the cytoplasm after the membrane potential decreases, resulting in fluorescence quenching, making it impossible to re-target mitochondria after the membrane potential is restored.

[0004] Of course, existing literature also reports a small number of fluorescent probes that can target other organelles (nucleus or lysosome) and continue to emit light after the mitochondrial membrane potential disappears. This type of probe can effectively overcome the diffusion effect of the fluorescent probe dissociating into the cytoplasm after the membrane potential decreases. Among them, the fluorescent probe targeting lysosomes is the representative, which can relocate the mitochondria after the membrane potential is restored, thereby realizing dynamic monitoring of the mitochondrial membrane potential. However, this type of probe is an organic small molecule fluorescent probe, and it is difficult to overcome the defect of photobleaching caused by the repeated migration of the probe in the mitochondria-lysosomes during long-term detection using confocal microscopy, which limits the detection of the mitochondrial membrane potential fluctuation process.

[0005] Therefore, finding a stable mitochondrial probe to detect the dynamic changes in mitochondrial membrane potential is an urgent problem that technicians in this field need to solve. Summary of the invention

[0006] In view of this, the present invention discloses a novel cyclometallated iridium (III) complex fluorescent probe and its preparation method and application. The metal complex molecule has good photophysical properties and can be used as a mitochondrial-lysosomal reversible migration fluorescent probe. Through long-term reversible migration, it can track and monitor the dynamic changes of mitochondrial membrane potential in cells in different physiological environments.

[0007] In order to achieve the above object, the present invention adopts the following technical solution:

[0008] An intermediate for synthesizing a novel cyclometallated iridium complex fluorescent probe, the structural formula of the intermediate is shown in Formula I:

[0009]

[0010] As an inventive concept identical to the above technical solution, the present invention also claims the use of the intermediate described in Formula I in the preparation of a novel cyclometallated iridium complex fluorescent probe.

[0011] As an inventive concept identical to the above technical solution, the present invention also claims protection for a novel cyclometallated iridium complex fluorescent probe, characterized in that the fluorescent probe is prepared from an intermediate shown in formula I, and the structural formula is shown in the following formula II;

[0012]

[0013] The positive charge structure of metallic iridium in the probe molecule is easily combined with the negative membrane potential of mitochondria through electrostatic interaction, so that the molecule is targeted and aggregated in the mitochondria and emits near-infrared fluorescence; as the negative membrane potential of mitochondria gradually decreases or even disappears, the probe molecule is released from the mitochondria, and the N atom of the pyridine group in 2-pyridine terpyridine is easily protonated under acidic conditions, prompting the probe to gradually migrate to the weakly acidic lysosomes, thereby realizing the migration of the probe and preventing it from diffusing in the cytoplasm.

[0014] As an inventive concept identical to the above-mentioned technical scheme, the present invention also requests protection for a method for preparing a novel cyclometallated iridium complex fluorescent probe shown in formula II, the process being: first using phenylpyridine and iridium trichloride as raw materials to synthesize an intermediate, and then mixing the intermediate with 2-pyridine terpyridine to prepare a novel cyclometallated iridium complex fluorescent probe M-Ir-L.

[0015] Compared with the prior art, the present invention uses phenylpyridine, iridium trichloride and 2-pyridine terpyridine as raw materials to simply and efficiently synthesize a cyclometallated iridium complex probe. The results of property research show that the metal complex molecule has good photophysical properties and can be used as a mitochondrial-lysosomal reversible migration fluorescent probe to track and detect the dynamic changes of intracellular mitochondrial membrane potential in different physiological environments through long-term reversible migration.

[0016] As a preferred technical solution of the above technical solution, the specific process of synthesizing the intermediate includes:

[0017] Under inert gas, phenylpyridine, iridium trichloride trihydrate, ethylene glycol monoethyl ether and deionized water were added to a light-proof container in sequence, and the ratio was 2.2mmol:0.353g:15ml:5ml; reacted at 110°C for 24h, cooled naturally to room temperature, filtered, purified, and vacuum dried to obtain an intermediate; the specific reaction formula is as follows:

[0018]

[0019] As a preferred technical solution of the above technical solution, the purification is: the filter residue after filtration is washed with water, alcohol and ether in sequence, and the intermediate 1 is obtained after complete drying; wherein each purification method is washed 3 times with a dosage of 1 ml.

[0020] As a preferred technical solution of the above technical solution, the specific process of mixing the intermediate with 2-pyridine terpyridine to prepare the novel cyclometallated iridium complex fluorescent probe M-Ir-L includes:

[0021] Under light-proof conditions, the intermediate, 2-pyridine terpyridine and methanol were added to the reaction, the ratio of each component was 0.107g:0.078g:50ml, the reaction was carried out at 65°C for 12h, the temperature was lowered to room temperature, and 0.2g of ammonium hexafluorophosphate was added and stirred for 30min, and then the mixture was dried and column chromatographed to obtain a new cyclometalated iridium complex fluorescent probe M-Ir-L; the specific reaction formula is as follows:

[0022]

[0023] As an inventive concept identical to the above technical solution, the present invention also claims the use of the fluorescent probe shown in Formula II in real-time monitoring of the dynamic changes of mitochondrial membrane potential. The probe is a cyclometalated iridium complex fluorescent probe used as a long-term dynamic monitoring of mitochondrial membrane potential during the reversible migration between mitochondria and lysosomes under different physiological environments of cells.

[0024] During the application process, the results showed that in live cell confocal imaging, low concentration (1μM) of the target molecule M-Ir-L and the liver cancer cell HepG-2 had a good overlap with the mitochondrial stain Mito-trackerdeepred after a short period of culture (5min). Under the action of CCCP, the located target molecule causes a decrease in mitochondrial membrane potential and will transfer from the mitochondria to the lysosomes, and the transfer efficiency is affected by the CCCP action conditions, that is, the rate of membrane potential decrease. After removing the CCCP intervention on the membrane potential, the positive charge structure of metal iridium promotes the migration of the probe back to the mitochondria, so that the mitochondria can be relocated from the lysosomes, and the strong photostability and sensitivity of the development of the target molecule can achieve multiple reversible migrations.

[0025] It can be seen from the above technical solution that the technical effects achieved by the present invention are:

[0026] The probe in the present invention is a cyclometal iridium complex with excellent optical properties. Based on the currently mature confocal microscopy imaging technology, it can be used as a mitochondrial-lysosome reversible migration fluorescent probe, and can track and detect the dynamic changes of mitochondrial membrane potential in cells in different physiological environments through long-term reversible migration. The migration principle of the probe is that the positive charge structure of metal iridium is easy to combine with the negative membrane potential of mitochondria through electrostatic action, locate the mitochondria and emit near-infrared fluorescence; the mitochondrial membrane potential gradually decreases or even disappears, and the probe molecule is released from the mitochondria. Since the N atom of the pyridine group in the 2-pyridine terpyridine in the target molecule is easy to be protonated under acidic conditions, the probe is prompted to gradually migrate to the weakly acidic lysosome to emit a fluorescent signal, thereby realizing the migration of the probe.

[0027] The probe molecule in the present invention is different from other mitochondrial-lysosomal dual-localization probes. Due to the good biocompatibility of terpyridine and the excellent photostability of the metal complex, the probe can migrate for a long time and multiple times. The convenient operation of quantitative fluorescence signal can be achieved through confocal imaging technology to monitor membrane potential, which has potential application value in real-time in situ monitoring of membrane potential changes in mitochondrial-related physiological processes. Moreover, the raw materials of the compounds in the present invention are easy to obtain, the synthesis route is short, the synthesis conditions are mild, the yield is high, and it is easy to commercialize. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0029] Figure 1The accompanying drawing is a hydrogen nuclear magnetic resonance spectrum analysis diagram of the probe M-Ir-L;

[0030] Figure 2 The attached figure is a mass spectrometry analysis diagram of probe M-Ir-L;

[0031] Figure 3 The attached figure is the UV-visible absorption spectrum of the probe M-Ir-L in a DMSO / PBS mixed solvent; wherein a is a spectrum diagram and b is a fluorescence emission diagram;

[0032] Figure 4 The attached figure shows the co-localization image of the probe M-Ir-L with the organelle stain in normal physiological cells; wherein, a is the co-localization image of the iridium complex and the mitochondrial stain, and the Pearson coefficient is 0.91; b is the co-localization image of the iridium complex and the mitochondrial stain, and the Pearson coefficient is 0.32;

[0033] Figure 5 The attached figure is a diagram showing the signal changes of the probe M-Ir-L and the commercial dye Rhodamine 123 targeting the mitochondrial membrane potential after the mitochondrial membrane potential changes;

[0034] Figure 6 The attached figure is a fluorescence signal analysis diagram of the probe M-Ir-L and the lysosome commercial staining during the disappearance of membrane potential; wherein, a is a real-time imaging diagram after low concentration 1 μM CCCP treatment; b is a bar graph of the change of the co-localization coefficient of the M-Ir-L signal and the lysosome commercial staining;

[0035] Figure 7 The attached figure is a graph showing the photostability analysis of the probe M-Ir-L and the mitochondrial commercial dye; wherein a is a confocal imaging graph of M-Ir-L and the mitochondrial commercial probe within 10 minutes; b is a graph showing the signal intensity analysis of M-Ir-L and the mitochondrial commercial dye;

[0036] Figure 8 The attached figure is an analysis diagram of the reversible migration signal of mitochondria-lysosomes in cells under different membrane potential physiological environments of the probe M-Ir-L; wherein, a is a real-time fluorescence co-localization image of M-Ir-L and lysosomal commercial dye in living cells after the membrane potential is reduced and restored by CCCP at multiple frequencies; b is a curve diagram of the change of the co-localization coefficient of the intracellular signal and the lysosomal commercial dye signal of the probe in multiple CCCP treatments. DETAILED DESCRIPTION

[0037] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0038] The sources of the reagents used in the embodiments of the present invention are: purchased from Shanghai Aladdin Reagent Co., Ltd.;

[0039] Example 1 Preparation and Characterization of Mitochondria-Lysosome Reversible Migration Cyclometalated Iridium Fluorescent Probe M-Ir-L

[0040] 1) Synthesis of intermediates

[0041] In a nitrogen atmosphere, add 2.2 mmol of phenylpyridine, 0.353 g (1 mmol) of iridium trichloride trihydrate, 15 mL of ethylene glycol monoethyl ether, and 5 mL of deionized water to a 100 mL two-necked Shrek reaction bottle protected from light, and heat to 110 °C for 24 h. Cool to room temperature, filter, and wash the residue with water (1 mL × 3), ethanol (1 mL × 3), and ether (1 mL × 3) in turn, and after complete drying, obtain the intermediate;

[0042] 2) Synthesis of probe M-Ir-L

[0043] Under light-proof conditions, 0.107 g (0.1 mmol) of iridium complex intermediate, 0.078 g (0.25 mmol) of 2-pyridine terpyridine and 50 mL of methanol were added to a 150 mL round-bottom flask, and the temperature was raised to 65 ° C for 12 h. After the reaction, the reaction temperature was lowered to room temperature, and 0.2 g of ammonium hexafluorophosphate was added and stirred for 30 min. After the reaction, 0.143 g of light yellow solid was obtained by spin drying and column chromatography, and the probe M-Ir-L was obtained with a yield of 75%.

[0044] The prepared probe M-Ir-L was analyzed by nuclear magnetic resonance hydrogen spectrum and mass spectrometry. Figure 1 and Figure 2 ; The results are as follows:

[0045] 1 H NMR(d6-DMSO,400MHz)δppm:9.18(s, 1 H),8.85(s, 1 H),8.78(d, 1 H),8.72(d, 1 H),8.18(dd, 3 H),8.07(d, 1 H),7.90(m, 6 H),7.68(d, 1 H),7.57(d, 1 H),7.52(dd, 1 H),7.44(m, 1 H),7.38(d, 1 H),7.16(dt, 2H),6.95(m, 3 H),6.74(m, 2 H),6.59(t, 1 H),6.31(t, 1 H),5.89(d, 1 H),5.45(d, 1 H).ESI-MS:m / z,calculated:811.22,found:811.25(M + ).

[0046] Example 2 Spectral properties of M-Ir-L probe in biological systems

[0047] Considering the water environment system of cells and the fact that DMSO is a non-protonic polar solvent and is a traditional stable and excellent solvent for fluorescent probes in biological applications, a DMSO / PBS mixed solvent was used to convert the DMSO-prepared M-Ir-L stock solution (1*10 -3 mol / L) diluted to 1*10 -5 mol / L, the sample pool used a double-transparent 1.0*1.0cm quartz cuvette and a fully transparent fluorescence cuvette, and their UV-visible absorption spectra in the range of 375-625nm and fluorescence emission spectra in the range of 450-800nm ​​were measured respectively; the results are shown in Figure 3 ,Depend on Figure 3 It can be seen that the maximum ultraviolet absorption peak of the probe is at 305nm, and the maximum fluorescence emission peak is at 650nm, which is consistent with the property that the metal complex probe has a large Stokes shift, which is conducive to its development in biological tissues.

[0048] Example 3 Analysis of the co-localization results of probe M-Ir-L and organelle staining in normal physiological cells

[0049] In live cell confocal imaging, 1 μmol / L probe diluted in cell culture medium was co-cultured with human liver cancer cell HepG-2 in an incubator for 10 minutes, then washed three times with PBS (pH=7.4) buffer, and then cultured in an incubator for 10 minutes with 1 μmol / L mitochondrial commercial dye Mito-tracker green and lysosomal commercial dye Lyso-tracker green, respectively. After washing three times with PBS, it can be directly used for imaging; the excitation wavelength of M-Ir-L is 405nm, and the emission band is 600-750nm. The excitation bands of mitochondrial commercial dye and lysosomal commercial dye are both 488nm, and the emission band is 500-540nm; the fluorescence imaging results are shown in Figure 4 , indicating that the probe targets mitochondria in normal physiological cells.

[0050] Example 4 Analysis of signal changes between probe M-Ir-L and commercial dye rhodamine 123 targeting mitochondrial membrane potential after changes in mitochondrial membrane potential

[0051] 1μmol / L probe M-Ir-L and HepG-2 were cultured in an incubator for 10 minutes, washed three times with PBS buffer, and then co-stained with 1μmol / L membrane potential-targeted mitochondrial commercial dye rhodamine 123 (excitation band 507nm, emission band 515-540nm), cultured in an incubator for 10 minutes, washed three times with PBS, and then directly used for development; then 10μmol / L CCCP prepared by cell culture medium was added and cultured for 10 minutes before confocal imaging. The development results of co-staining with rhodamine 123 before and after adding membrane potential scavenger are shown in Figure 5 ; This indicates that M-Ir-L migrates to other organelles after the membrane potential disappears, while the membrane potential-dependent rhodamine 123 loses its membrane potential targeting and diffuses in the cytoplasm.

[0052] Example 5 Analysis of fluorescence signals of probe M-Ir-L in the process of membrane potential disappearance and lysosome cross-talk

[0053] In order to observe the migration site of the target molecule after the membrane potential is reduced, the attached HepG-2 cells were cultured with 1μmol / L of the target molecule and 1μmol / L of the lysosomal commercial dye Lyso-tracker green for 10 minutes respectively, and washed three times with PBS to remove the excess dye. The glass-bottomed culture dish was placed in the living cell workstation equipped with a laser confocal microscope for culture, and then 1μmol / L of CCCP was added to induce a gradual decrease in the mitochondrial membrane potential. The co-localization of the dot signal of M-Ir-L and the lysosome was observed at 5min, 10min, 20min, and 30min. CCCP could not be removed during the imaging process, and the co-localization Pierce coefficient (Rr) of the two increased from 0.29 to 0.85. Experimental results Figure 6 It shows that the N atom of the pyridine group in 2-pyridine terpyridine in the target molecule M-Ir-L is easily protonated under acidic conditions and migrates to the lysosome during the decrease of membrane potential, prompting the probe to gradually migrate to the weakly acidic lysosome and emit a fluorescent signal.

[0054] Example 5 Analysis of the photostability of probe M-Ir-L and mitochondrial commercial dyes

[0055] After co-staining the cells with the probe M-Ir-L and the mitochondrial commercial dye as in Example 3, the cell samples were collected using the signal collection band of Example 3 and the same power of 1 W / cm 2 The laser scans continuously for 10 minutes. The imaging results are shown in Figure 7, during long-term fluorescence imaging, the probe M-Ir-L, as a cyclometallated complex, has good photostability and can be used for long-term real-time imaging detection.

[0056] Example 6

[0057] The cells were stained under the same experimental conditions as in Example 3, and then 10 μmol / L CCCP was added to induce a decrease in mitochondrial membrane potential. The results are as follows: Figure 8 In the living cell workstation, it was observed that the M-Ir-L signal gradually migrated to the lysosome during the disappearance of membrane potential; then, CCCP in the cells was eluted with PBS buffer, and fresh cell complete culture medium was added to continue culturing the cells. The fluorescence overlap between the probe M-Ir-L and the lysosomal commercial dye gradually weakened, and the co-localization Pierce correlation coefficient between the two gradually decreased to 0.32, indicating that during the recovery of mitochondrial membrane potential, M-Ir-L migrated from the lysosome to the mitochondria, indicating that the target molecule can achieve reversible migration from mitochondria to lysosomes; after adding 10μmol / L CCCP to induce a further decrease in mitochondrial membrane potential, the co-localization Rr value of the M-Ir-L signal and the lysosomal fluorescence signal was continuously observed to gradually increase to 0.81. The experimental results show that the target molecule can achieve long-term reversible migration tracking and detection of dynamic changes in mitochondrial membrane potential in cells under different physiological environments.

[0058] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0059] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A cyclometallated iridium complex fluorescent probe, It is characterized in that The fluorescent probe is prepared from the intermediate shown in formula I, and the structural formula is shown in the following formula II; AND; II; The preparation process of the intermediate shown in Formula I comprises: Under inert gas, phenylpyridine, iridium trichloride trihydrate, ethylene glycol monoethyl ether and deionized water were added to a light-proof reactor in order in the ratio of 2.2 mmol: 0.353 g: 15 ml: 5 ml, respectively. The mixture was reacted at 110 °C for 24 h, cooled naturally to room temperature, filtered, purified and vacuum dried to obtain an intermediate. The specific reaction formula is as follows: 。 2. A cyclometallated iridium complex fluorescent probe according to claim 1, It is characterized in that The purification process of the intermediate preparation process shown in formula I is as follows: the filter residue after filtration is washed with water, alcohol, and ether in sequence, and the intermediate I is obtained after complete drying; wherein each purification method is washed 3 times with a dosage of 1 ml.

3. A method for preparing a cyclometallated iridium complex fluorescent probe according to claim 1 or 2, It is characterized in that The intermediate shown in formula I is mixed with 2-pyridine terpyridine to prepare the cyclometalated iridium complex fluorescent probe M-Ir-L.

4. The method for preparing a cyclometallated iridium complex fluorescent probe according to claim 3, It is characterized in that The specific process of preparing the cyclometallated iridium complex fluorescent probe M-Ir-L is as follows: Under light-proof conditions, the intermediate shown in formula I, 2-pyridine terpyridine, and methanol were added to the reactor in a ratio of 0.107 g: 0.078 g: 50 ml; the reaction was carried out at 65°C for 12 h, the temperature was lowered to room temperature, and 0.2 g of ammonium hexafluorophosphate was added and stirred for 30 min, and the mixture was dried and subjected to column chromatography to obtain the cyclometalated iridium complex fluorescent probe M-Ir-L; the specific reaction formula is as follows: 。